Industry

Life Sciences.

Life Sciences, medical devices, digital health.

Specialty pharma, medical devices, diagnostics, digital health, and biotech are heavily regulated, R&D-intensive businesses, where consolidation is driven by international players. Montesino advises entrepreneurs on sales to international pharma groups and healthcare funds, and works with PE funds on build-ups in the Italian mid-market.

Who it's for

International consolidation.

Italian companies, specialized funds, and big pharma operate in a sector that is concentrating across Europe.

Typical client

Italian companies

Pharma, biotech, medical devices, and healthcare service providers: typically family- or founder-controlled.

Typical client

Specialized funds

Healthcare-focused PE and biotech venture capital active in the European mid-market for acquisitions, exits, and scale-up transactions.

Typical client

Global strategics

Big pharma, international medical device groups, and digital health operators seeking Italian assets with distinctive positioning.

What we do

Sales and licensing.

Value depends on the product, the pipeline, and the regulatory framework. Montesino has access to investors specialized in the sector.

Type

Sales to strategics

Sell-side advisory for founders and families toward big pharma or medical device groups.

Type

Capital raising

Rounds for scale-up operators, from Series A to growth.

Type

Licensing and partnerships

Structuring of commercial agreements with corporate implications (royalties, milestones, equity).

Type

Cross-border transactions

Coordination of complex deals with international counterparties and multiple regulators.

Industry insight

Industry research.

REPORT

Sector map and key players

Montesino Research

NOTE

Consolidation trends and recent M&A activity

Montesino Research

ARTICLE

Current multiples and valuation benchmarks

Montesino Research

REPORT

Cross-border outlook and international investors

Montesino Research